All questionsSpecific populations: Kisqali (ribociclib), all indications6 questions · 1 sourcePregnancy and breastfeedingCan Kisqali be taken during pregnancy?“Based on findings from animal studies and the mechanism of action, KISQALI can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology (12.1)]. There are no available human data informing the drug-associated risk. In animal reproduction studies, administration of ribociclib to pregnant animals during organogenesis resulted in increased incidences of post implantation loss and reduced fetal weights in rats and increased incidences of fetal abnormalities in rabbits at exposures 0.6 or 1.5 times the exposure in humans, respectively, at the highest recommended dose of 600 mg/day based on AUC (see Data). Advise pregnant women of the potential risk to a fetus.” (opens the source at this quote in a new tab)CopyFlag“Pregnancy Testing Verify pregnancy status in females of reproductive potential prior to starting treatment with KISQALI.” (opens the source at this quote in a new tab)CopyFlagHow long is birth control needed after stopping Kisqali?“Advise females of reproductive potential to use effective contraception (methods that result in less than 1% pregnancy rates) during treatment with KISQALI and for at least 3 weeks after the last dose.” (opens the source at this quote in a new tab)CopyFlagCan Kisqali be taken while breastfeeding?“It is not known if ribociclib is present in human milk. There are no data on the effects of ribociclib on the breastfed infant or on milk production. Ribociclib and its metabolites readily passed into the milk of lactating rats. Because of the potential for serious adverse reactions in breastfed infants from KISQALI, advise lactating women not to breastfeed while taking KISQALI and for at least 3 weeks after the last dose.” (opens the source at this quote in a new tab)CopyFlag“In lactating rats administered a single dose of 50 mg/kg, exposure to ribociclib was 3.56-fold higher in milk compared to maternal plasma.” (opens the source at this quote in a new tab)CopyFlagSpecific populationsCan Kisqali affect male fertility?“Based on animal studies, KISQALI may impair fertility in males of reproductive potential [see Nonclinical Toxicology (13.1)].” (opens the source at this quote in a new tab)CopyFlagIs Kisqali approved for children?“The safety and effectiveness of KISQALI in pediatric patients have not been established.” (opens the source at this quote in a new tab)CopyFlagWhat is the Kisqali dose for kidney (renal) impairment?“No dose adjustment is necessary in patients with breast cancer who have mild to moderate (30 mL/min to 89 mL/min/1.73 m2 ≤ estimated glomerular filtration rate (eGFR)) renal impairment. A reduced starting dose of 200 mg is recommended in patients with breast cancer who have severe renal impairment [see Dosage and Administration (2.2), Clinical Pharmacology (12.3)].” (opens the source at this quote in a new tab)CopyFlag“In adults with severe renal impairment and end stage renal disease, ribociclib AUCinf increased 2.4-fold and 3.8-fold, and Cmax increased 2.1-fold and 2.7-fold relative to the exposure in adults with normal renal function.” (opens the source at this quote in a new tab)CopyFlag